Business profile & competitive position
Nordson Corporation operates in the Industrials sector, specifically the Industrial - Machinery industry, engineering and selling precision-dispense, coating, polymer, sealant, adhesive, fluid-control, and quality-inspection systems. It also manufactures medical components such as catheters, cannulas, balloons, and tubing through three segments: Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions. The business model relies on a direct sales force plus qualified distributors, selling differentiated equipment typically embedded in customer production lines where switching costs tend to be high.
The margin and return data support the idea that this specialization translates into pricing power and capital efficiency. The trailing net margin is 18.6% and return on equity is 17.6%. Those figures sit well above the machinery-sector average, suggesting the company is not competing on commodity hardware alone. No single customer accounts for 10% or more of sales, which reduces concentration risk and reinforces the view that the competitive moat is distributed across a broad base of sticky, precision-manufacturing customers.
Financial posture
Nordson carries a market capitalization of $17.7 billion and trades at a P/E ratio of 32.1 as of the snapshot date, with the stock at $318.36. That multiple is consistent with a high-quality industrial compounder rather than a deep-value cyclical machinery name. The 18.6% net margin and 17.6% ROE help justify the premium, though the P/E also leaves limited room for operational disappointment relative to lower-multiple peers.
Beta is 0.97, essentially market-neutral, and the current RSI of 53.2 shows the stock near neither overbought nor oversold territory relative to its 50-day EMA of $308.12. The balance between profitability and valuation means investors are effectively paying for continued execution on margin and growth; the numbers do not suggest a bargain-basement entry, nor do they point to obvious downside acceleration.
Strategic priorities & outlook
Nordson's most recent 10-K frames the company as an "innovative precision technology company" and highlights the Ascend strategy launched in 2021. The strategic playbook has three stated pillars: the NBS Next growth framework, an Owner Mindset division-led structure, and the Winning Teams talent strategy. Operationally, management says it targets top-tier revenue growth with leading margins and returns, using data-based segmentation to direct investment toward the most profitable opportunities.
Organic growth drivers include continual new-product introduction, customer service and support, expansion in emerging geographies, and applying existing technology to new applications. On the M&A side, the company looks for precision-technology targets with differentiated product portfolios, high-growth end-market exposure, and customer-centric models that can broaden the precision-solution set and diversify end markets. Geographically, the filing notes direct operations in more than 35 countries and approximately 67% of 2025 revenues came from outside the United States, while principal manufacturing facilities are located in the United States, China, Bulgaria, Germany, Ireland, Israel, Italy, Mexico, the Netherlands, and the United Kingdom. The company also reported stabilization of global supply chains, improved lead times, and lower inflation risk, while flagging ongoing volatility in Asia-origin shipments and moderate rate increases in parcel and domestic trucking as residual watch items.
Macro & geopolitical exposure
The Industrial - Machinery classification implies sensitivity to capital spending cycles, factory automation demand, industrial-production indices, and global trade flows. For Nordson specifically, the 67% non-U.S. revenue share means foreign-exchange translation, cross-border tariff policy, and regional manufacturing-capacity trends are material variables. Because it operates facilities across North America, Europe, the Middle East, and Asia, including China, supply-chain routing and geopolitical friction around Asia-origin shipments are relevant.
Interest-rate levels also matter: higher rates normally slow customer capital-investment decisions and can pressure valuation multiples for industrials. Conversely, lower rates and reshoring/factory-automation trends can support demand for precision dispensing, coating, inspection, and medical-product equipment. Energy and raw-material input costs affect margin, though the company's 18.6% net margin indicates it has maintained pricing power through recent cost cycles.
Recent developments
Recent news coverage has centered on capital return and relative valuation. On August 31, 2026, Zacks reported that Nordson rewarded investors with a 15% dividend hike, citing strong cash flow. The same day, Zacks also published an "MWA vs. NDSN: Which Stock Is the Better Value Option?" comparison and 247WallSt included Nordson in "3 Dividend Stocks with Unbelievable Streaks but Barely Pay Investors." On September 4, 2026, Zacks again featured Nordson among "4 Stocks to Buy That Declared Dividend Hikes Amid Geopolitical Woes." The recurring theme across these headlines is confidence in free-cash generation sufficient to raise the dividend even as macro and geopolitical uncertainty persists.
Earnings behavior & post-earnings drift
Nordson's earnings track record over the last eight reported quarters shows a beat rate of 6 out of 8, or 86%, with an average earnings surprise of 2.7%. The average 5-day price move in the trading sessions following those reports is 2.55%, classified as an "up" drift. That pattern suggests the market has generally underweighted the company's ability to execute, allowing positive news to be absorbed gradually rather than fully priced in overnight.
The most recent four quarters illustrate both the resilience and the occasional mixed reaction. For the August 19, 2026 report, Nordson delivered EPS of $3.25 against a $3.09 estimate, a 5.2% surprise; the stock rose 8% the next session and 7.96% over the following five days. The May 20, 2026 quarter produced a $2.86 actual versus a $2.82 estimate, a 1.4% beat, with a 3.83% one-day gain and 4.32% five-day drift. The February 18, 2026 quarter was exactly in line at $2.37 versus $2.37, and the stock sold off 1.79% the next day and 2.83% over the next five sessions, showing that merely meeting the unofficial consensus can disappoint. The December 10, 2025 report beat by 3.4% with $3.03 versus $2.93, yet the stock slipped 0.80% the next day before drifting back to a 0.74% five-day gain.
Looking ahead, the next scheduled earnings date is December 9, 2026 after the close, with the current consensus EPS estimate at $3.45. The historical beat rate and positive post-earnings drift are useful context for framing expectations around that report, though past behavior does not guarantee how the price will respond.
Frequently Asked Questions
What does Nordson actually do?
Nordson is an industrial-machinery company that designs and manufactures precision technology used to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids. It also provides systems for quality inspection, surface treatment, curing, and the production of medical components such as catheters, cannulas, balloons, and tubing.
How has Nordson historically performed around earnings?
Over the last eight reported quarters, Nordson has beaten earnings estimates six times, an 86% beat rate, with an average surprise of 2.7%. The average five-session move after those reports is 2.55%, classified as an upward post-earnings drift.
What are Nordson's main strategic priorities?
The company is executing the Ascend strategy launched in 2021, built on three pillars: the NBS Next growth framework for data-driven resource allocation, an Owner Mindset division-led structure, and a Winning Teams talent strategy. It also pursues organic growth through new products and geographic expansion, plus acquisitions of differentiated precision-technology companies.
For a deeper dive into how institutions are currently modeling revenue, margin, and risk scenarios around Nordson, review the full institutional verdict and consensus-derived research rather than relying on headline data alone.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-19 | $3.25 | $3.09 | +5.2% | +8% | +7.96% |
| 2026-05-20 | $2.86 | $2.82 | +1.4% | +3.83% | +4.32% |
| 2026-02-18 | $2.37 | $2.37 | 0% | -1.79% | -2.83% |
| 2025-12-10 | $3.03 | $2.93 | +3.4% | -0.8% | +0.74% |
| 2025-08-20 | $2.73 | $2.64 | +3.4% | - | - |
| 2025-05-28 | $2.42 | $2.36 | +2.5% | - | - |
Previous NDSN editions
Get the institutional verdict on NDSN
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the NDSN verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.